Covaxin emergency use decision likely in 4-6 weeks: WHO

The World Health Organization is likely to take a decision on including Bharat Biotech's COVID-19 vaccine Covaxin in the emergency use list (EUL) within four to six weeks, Soumya Swaminathan, the......

DCGI approves Covovax for emergency use in 12-17 yrs age group

India's drug regulator has granted restricted emergency use authorisation to Serum Institute's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions. IMAGE: A......

Govt approves 2 new vaccines, Covid drug for emergency use

Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drugs Standard Control Organisation (CDSCO) has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological......

UK to add India's Covaxin to approved list from Nov 22

The United Kingdom government has said that India's Covaxin will be added to its list of approved COVID-19 vaccines for international travellers from November 22, meaning that those inoculated with......